Advertisement
Canada markets open in 53 minutes

  • S&P/TSX

    21,871.96
    +64.59 (+0.30%)
     

  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     

  • DOW

    38,239.98
    +253.58 (+0.67%)
     

  • CAD/USD

    0.7300
    -0.0001 (-0.02%)
     

  • CRUDE OIL

    81.07
    -0.83 (-1.01%)
     

  • Bitcoin CAD

    90,508.84
    +134.32 (+0.15%)
     

  • CMC Crypto 200

    1,419.43
    +4.67 (+0.33%)
     

  • GOLD FUTURES

    2,323.70
    -22.70 (-0.97%)
     

  • RUSSELL 2000

    1,967.47
    +19.82 (+1.02%)
     

  • 10-Yr Bond

    4.6460
    +0.0230 (+0.50%)
     

  • NASDAQ futures

    17,387.00
    +37.00 (+0.21%)
     

  • VOLATILITY

    16.69
    -0.25 (-1.48%)
     

  • FTSE

    8,025.09
    +1.22 (+0.02%)
     

  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     

  • CAD/EUR

    0.6840
    -0.0010 (-0.15%)
     

New Strong Sell Stocks for December 9th

Zacks Equity Research
·1 min read

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

GreenTree Hospitality Group Ltd. GHG develops leased-and-operated and franchised-and-managed hotels. The Zacks Consensus Estimate for its current year earnings has been revised 6.5% downward over the last 30 days.

Neurocrine Biosciences, Inc. NBIX is a commercial-stage biopharmaceutical company that discovers and develops therapeutics for the treatment of neurological, endocrine, and psychiatric disorders. The Zacks Consensus Estimate for its current year earnings has been revised 40.5% downward over the last 30 days.

Solid Biosciences Inc. SLDB is a life science company, engages in developing therapies for duchenne muscular dystrophy. The Zacks Consensus Estimate for its current year earnings has been revised 3.9% downward over the last 30 days.

ADVERTISEMENT

Fennec Pharmaceuticals Inc. FENC is a biopharmaceutical company that develops product candidates for use in the treatment of cancer. The Zacks Consensus Estimate for its current year earnings has been revised 5% downward over the last 30 days.

NewAge, Inc. NBEV develops, markets, sells, and distributes healthy liquid dietary supplements and ready-to-drink beverages. The Zacks Consensus Estimate for its current year earnings has been revised 31.3% downward over the last 30 days.

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Neurocrine Biosciences, Inc. (NBIX) : Free Stock Analysis Report
 
New Age Beverage Corporation (NBEV) : Free Stock Analysis Report
 
Adherex Technologies Inc. (FENC) : Free Stock Analysis Report
 
Solid Biosciences Inc. (SLDB) : Free Stock Analysis Report
 
GreenTree Hospitality Group Ltd. Sponsored ADR (GHG) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research